Professor Liz Shanahan Founder and Chief Executive of Kingdom Therapeutics

episode

Breakfast Business with Joe Lynam not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

More from Breakfast Business with Joe Lynam

K-shaped economy 6 min · 23 Dec 2025

Medtech firm secures funding to support its push for US regulatory clearance 8 min · 23 Dec 2025

Tuesday's business headlines 3 min · 23 Dec 2025

Volatile Geopolitics the New Norm 7 min · 22 Dec 2025

Monday's business headlines 9 min · 22 Dec 2025

A positive picture for the domestic economy 7 min · 19 Dec 2025

All episodes from Breakfast Business with Joe Lynam →

Report any issue

Source

Recorded12 Feb 2025

Publisherrss.podplaystudio.com

Handlerec:9174402

Show notes

ASD or Autism Spectrum Disorder, affects how young people communicate with others, if they do at all and for some, they can never lead independent lives. One medical research company in Co Kerry hopes to find a treatment for those with ASD and has started clinical trials of a new drug which could be transformative. But getting from trials to the pharmacy shelves is a complicated and often very expensive process. Joe was joined on the show this morning by Professor Liz Shanahan the Founder and Chief Executive of Kingdom Therapeutics.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in